Smart Labels Market by Type of Technology, Type of Packaging, Type of Primary Packaging, Type of Secondary Packaging and Key Geographical Regions - Industry Trends and Global Forecasts, 2022-2035

The annual market for counterfeit drugs is estimated to be USD 200 billion and this value is believed to be expanding rapidly. As per a report published by the World Health Organization (WHO), 20% of counterfeit pharmaceuticals include an incorrect amount of the active ingredient, while 30% of the counterfeit drugs contain no active ingredient at all. Such illegal practices are likely to endanger the lives of the patients, as well as tarnish the developer company's reputation. In order to overcome the aforementioned concerns, label service providers have strengthened the ongoing labelling practices and are shifting towards smart labelling technologies. A smart label comprises of printed information, a bar code identifier and a small transponder. This transponder contains a processing chip and an antenna that allows physical objects to communicate with the tag reader (for instance, RFID reader). Smart labels offer several benefits, such as tracing and tracking products in a supply chain, and tamper proofing, discouraging counterfeiters from packaging fake drugs. In this context, it is worth mentioning that the smart labelling technology is expected to save USD 0.8 - 1.5 million per year per company, through their applications in inventory management. Despite numerous growth drivers for adopting smart label technologies, there are some factors that may hinder the immediate uptake of smart label technologies. These include high price of integrating the technology as well as lack of well-established regulatory standards across the globe. Such considerations may also prevent investment opportunities for smart label technologies. It is worth highlighting that, in the recent years, consortiums, such as GS1 standards and RAIN Alliance, have been established to standardize global regulations.

At present, various types of smart labels, including radio frequency identification device labels (RFID), internet of things (IoT) labels, bluetooth labels and others, are being deployed across various applications in the pharmaceutical and healthcare markets; these include supply chain management, asset tracking, patient tracking and clinical trial labelling. Currently, more than 90 companies are engaged in providing these labels for various applications. In addition, with an aim to diversify their area of application and enhance their existing product portfolios, players engaged in providing smart pharmaceutical and healthcare labels are actively collaborating with other industry stakeholders. It is also worth mentioning that over 400 patents related to smart labels have been filed / granted, highlighting the continuous pace of innovation in this field. Driven by the growing demand for authentic and efficient drugs and ongoing efforts of players to integrate sophisticated features in the product design and affiliated technology, the smart pharmaceutical and healthcare labels market is likely to witness noteworthy growth over the coming years.

SCOPE OF THE REPORT

The "Smart Pharmaceutical and Healthcare Labels Market by Type of Technology (RFID, NFC and Other Technologies), Type of Packaging (Primary Packaging and Secondary Packaging), Type of Primary Packaging (Vials, Syringes, Cartridges, Ampoules, Bottles and Blister Packs), Type of Secondary Packaging (Boxes, Cartons and Pouches) and Key Geographical Regions (North America, Europe, Asia Pacific, MENA and Latin America) - Industry Trends and Global Forecasts, 2022-2035" report features an extensive study of the current market landscape and future opportunities associated with the smart pharmaceutical and healthcare labels, offering in-depth analyses of the various business entities engaged in this domain, across key global regions. Amongst other elements, the report includes:

A brief overview of smart labels, along with the information on their role and advantages in healthcare sector, along with details on the types of smart labels, featuring their applications in the pharmaceutical and healthcare domain. In addition, it includes a discussion on various challenges associated with the adoption of smart labels, future perspectives, and the factors driving the smart pharmaceutical and healthcare labels industry.
A detailed review of the overall landscape of players engaged in the smart pharmaceutical and healthcare label providers domain, along with information on type of technology (including RFID labels, Bluetooth labels, sensing labels and IoT labels), RFID frequency band (low frequency, high frequency, NFC and ultra-high frequency and unspecified) and area(s) of application (supply chain management, asset tracking, patient centricity, patient tracking, payment tracking, product authentication, clinical trial labelling, blood bag management, other application(s))
A detailed competitiveness analysis of companies engaged in the development of smart pharmaceutical and healthcare labels, based on their supplier strength (in terms of years of experience and company size), service strength (based on the type of area(s) of application and type of RFID frequency band) and portfolio strength (in terms of number of technology).
Elaborate profiles of prominent players (shortlisted on the basis of number of application area and company size) that claim to specialize in offering smart pharmaceutical and healthcare labels. Each profile features a brief overview of the company, along with information on their year of establishment, number of employees, location of headquarters, key executives, as well as details related to their smart labels focused portfolio, recent developments and an informed future outlook.
An in-depth analysis of patents related to smart pharmaceutical and healthcare labels that have been filed / granted till date, based on several relevant parameters, such as type of patent, publication year, geographical location / patent jurisdiction, legal status, CPC symbols, type of industry, type of applicant and leading players (in terms of number of patents filed / granted). In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents filed / granted in this industry.
A detailed analysis of the partnerships and collaborations inked in the domain, during the period 2018-2022, based on several parameters, such as year of partnership, type of partnership, most active player and region.
A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market, featuring thirteen strategic tools that can help software developers to shift towards a blue ocean strategic market.
A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry's evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall smart pharmaceutical and healthcare labels market.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the smart pharmaceutical and healthcare labels market, over the coming years. We have provided informed estimates on the evolution of the market in the short to mid-term and mid to long term, for the period 2022-2035. Additionally, our year-wise projections of the current and future opportunity have been segmented based on relevant parameters, such as [A] type of technology (RFID Labels, NFC Labels and other Labels), [B] type of packaging (primary packaging and secondary packaging), [C] type of primary packaging (vials, syringes, cartridges, ampoules, bottles and blister packs), [D] type of secondary packaging (boxes, cartons and pouches) and [E] key geographical regions (North America, Europe, Asia Pacific, MENA and Latin America). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY

The data presented in this report has been gathered and secondary research. For all our projects, we conduct interviews with the domain experts (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw an opinion on how the market will evolve across different regions and technology segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:

Annual reports
Investor presentations
SEC filings
Industry databases
News releases from company websites
Government policy documents
Industry analysts' views

While the report focuses on forecasting the market till 2035, it also provides our independent view on various emerging trends in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market, gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED

Who are the leading players engaged in the development of smart pharmaceutical and healthcare labels?
What is the relative competitiveness of different smart pharmaceutical and healthcare labels providers?
Which type of partnership models are most commonly being adopted by stakeholders engaged in this domain?
What are the key strategies that can be implemented by emerging players / start-ups to enter the highly competitive market for smart labels?
Which companies are actively filing patents to drive innovation in the field of smart pharmaceutical and healthcare labels?
What are the key challenges associated within the smart pharmaceutical and healthcare labels market?
What is the current / likely future market size of smart pharmaceutical and healthcare labels?

CHAPTER OUTLINES

Chapter 2: is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of the smart pharmaceutical and healthcare labels market and its likely evolution in the short to mid-term, and long term.

Chapter 3: A brief overview of smart labels, along with the information on their role and advantages in healthcare sector. Further, it highlights the types of smart labels, along with their applications in the pharmaceutical and healthcare domain. The chapter further mentions various challenges associated with the adoption of smart pharmaceutical and healthcare labels. In addition, it includes a discussion on future perspectives for this market, specifically highlighting the factors driving the smart pharmaceutical and healthcare labels industry.

Chapter 4: provides a detailed review of the overall landscape of players engaged in the smart pharmaceutical and healthcare label providers domain, along with information on type of technology (including RFID labels, Bluetooth labels, sensing labels and IoT labels), RFID frequency band (low frequency, high frequency, NFC and ultra-high frequency and unspecified) and area(s) of application (supply chain management, asset tracking, patient centricity, patient tracking, payment tracking, product authentication, clinical trial labelling, blood bag management, other application(s))

Chapter 5: provides a detailed competitiveness analysis of companies engaged in the development of smart pharmaceutical and healthcare labels, based on their supplier strength (in terms of years of experience and company size), service strength (based on the type of area(s) of application and type of RFID frequency band) and portfolio strength (in terms of number of technology).

Chapter 6: provides elaborate profiles of prominent players (shortlisted on the basis of number of application area and company size) that claim to specialize in offering smart pharmaceutical and healthcare labels. Each profile features a brief overview of the company, along with information on their year of establishment, number of employees, location of headquarters, key executives, as well as details related to their smart labels focused portfolio, recent developments and an informed future outlook.

Chapter 7: provides an in-depth analysis of patents related to smart pharmaceutical and healthcare labels that have been filed / granted till date, based on several relevant parameters, such as type of patent, publication year, geographical location / patent jurisdiction, legal status, CPC symbols, type of industry, type of applicant and leading players (in terms of number of patents filed / granted). In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents filed / granted in this industry.

Chapter 8: provides a detailed analysis of the partnerships and collaborations inked in the domain, during the period 2018-2022, based on several parameters, such as year of partnership, type of partnership, most active player and region.

Chapter 9: provides a detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market, featuring thirteen strategic tools that can help software developers to shift towards a blue ocean strategic market.

Chapter 10: presents an insightful market forecast analysis, highlighting the likely growth of smart pharmaceutical and healthcare labels market till 2035. Additionally, our year-wise projections of the current and future opportunity have further been segmented based on several relevant parameters, such as type of technology (RFID labels, NFC labels and Other labels), type of packaging (primary packaging and secondary packaging), primary packaging (vials, syringes, cartridges, ampoules, bottles and blister packs), secondary packaging (boxes, cartons and pouches) and key geographical regions (North America, Europe, Asia Pacific, MENA and Latin America).

Chapter 11: provides a detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry's evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall smart pharmaceutical and healthcare labels market.

Chapter 12: summarizes the overall report, wherein we have mentioned all the key facts and figures described in the previous chapters. The chapter also highlights important evolutionary trends that were identified during the course of the study and are expected to influence the future of the smart pharmaceutical and healthcare labels market.

Chapter 13: is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 14: is an appendix, which contains a list of companies and organizations mentioned in this report.

Product Code: RA100402

1. PREFACE

1.1. Scope of the Report
1.2. Market Segmentations
1.3. Research Methodology
1.4. Frequently Asked Answered
1.5 Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. Role of Smart Labels in the Healthcare Sector
- 3.2.1 Types of Smart Labels
  - 3.2.1.1. Radio Frequency Identification Device (RFID)
  - 3.2.1.2. Near-Field Communication (NFC)
  - 3.2.1.3. Internet of Things (IoT)
- 3.2.2. Need for Smart Labels in the Healthcare Sector
- 3.2.3. Advantages of Using Smart Labels in Healthcare Sector
3.3. Roadblocks and Challenges Associated with the Adoption of Smart Labels
3.4. Adoption of Smart Labels in the Healthcare Sector
- 3.4.1. Key Drivers for Adoption of Smart Labels
3.5. Future Outlook

4. MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Smart Pharmaceutical and Healthcare Label Providers: Overall Market Landscape
- 4.2.1. Analysis by Year of Establishment
- 4.2.2. Analysis by Company Size
- 4.2.3. Analysis by Location of Headquarters
- 4.2.4. Analysis by Company Size and Location of Headquarters
- 4.2.5. Analysis by Type of Technology
- 4.2.6. Analysis by Company Size and Type of Technology
- 4.2.7. Analysis by Type of RFID Frequency Band
- 4.2.8. Analysis by Area(s) of Application
- 4.2.9. Analysis by Company Size and Area(s) of Application
- 4.2.10. Analysis by Type of Technology and Area(s) of Application

5. COMPANY COMPETITIVENESS ANALYSIS

5.1. Chapter Overview
5.2. Assumptions / Key parameter
5.3. Methodology
- 5.3.1. Smart Pharmaceutical and Healthcare Label Providers based in North America
- 5.3.2. Smart Pharmaceutical and Healthcare Label Providers based in Europe
- 5.3.3. Smart Pharmaceutical and Healthcare Label Providers based in Asia-Pacific
5.4. Company Competitiveness Analysis: Benchmarking the Capabilities of Leading Players

6. COMPANY PROFILES

6.1. Chapter Overview
6.2. CCL Industries
- 6.2.1. Company Overview
- 6.2.2. Financial Information
- 6.2.3. Area(s) of Application
- 6.2.4. Recent Developments and Future Outlook
6.3. Schreiner
- 6.3.1. Company Overview
- 6.3.2. Area(s) of Application
- 6.3.3. Recent Developments and Future Outlook
6.4. Datalogic
- 6.4.1. Company Overview
- 6.4.2. Financial Information
- 6.4.3. Area(s) of Application
- 6.4.4. Recent Developments and Future Outlook
6.5. Tadbik
- 6.5.1. Company Overview
- 6.5.2. Area(s) of Application
- 6.5.3. Recent Developments and Future Outlook
6.6. SATO
- 6.6.1. Company Overview
- 6.6.2. Financial Information
- 6.6.3. Area(s) of Application
- 6.6.4. Recent Developments and Future Outlook
6.7. Invengo
- 6.7.1. Company Overview
- 6.7.2. Area(s) of Application
- 6.7.3. Recent Developments and Future Outlook
6.8. Intellhydro Technology
- 6.8.1. Company Overview
- 6.8.2. Area(s) of Application
- 6.8.3. Recent Developments and Future Outlook
6.9. RFiD Discovery
- 6.9.1. Company Overview
- 6.9.2. Area(s) of Application
- 6.9.3. Recent Developments and Future Outlook
6.10. ID Tech Solutions
- 6.10.1. Company Overview
- 6.10.2. Area(s) of Application
- 6.10.3. Recent Developments and Future Outlook

7. PATENT ANALYSIS

7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Smart Pharmaceutical and Healthcare Labels: Patent Analysis
- 7.3.1. Analysis by Publication Year
- 7.3.2. Analysis by Publication Year and Type of Patent
- 7.3.3. Analysis by CPC Code
- 7.3.4. Analysis by Type of Applicant
- 7.3.5. Analysis by Geography
- 7.3.6. Analysis by Emerging Focus Areas
- 7.3.7. Leading Industry Players: Analysis by Number of Patents
7.4. Smart Pharmaceutical and Healthcare Labels: Patent Benchmarking Analysis
- 7.4.1. Analysis by Patent Characteristics
7.5. Smart Pharmaceutical and Healthcare Labels: Patent Valuation Analysis

8. PARTNERSHIPS AND COLLABORATIONS

8.1. Chapter Overview
8.2. Partnership Models
8.3. Smart Pharmaceutical and Healthcare Labels: Recent Partnerships and Collaborations
- 8.3.1. Analysis by Year of Partnership
- 8.3.2. Analysis by Type of Partnership
- 8.3.3. Most Active Players: Analysis by Number of Partnerships
- 8.3.4. Regional Analysis
  - 8.3.4.1. Local and International Agreements
  - 8.3.4.2. Intercontinental and Intracontinental Agreements

9. BLUE OCEAN STRATEGY

9.1. Chapter Overview
9.2. Overview of Blue Ocean Strategy
- 9.2.1 Red Ocean
- 9.2.2 Blue Ocean
- 9.2.3 Comparison of Red Ocean Strategy and Blue Ocean Strategy
- 9.2.4. Smart Pharmaceuticals and Healthcare Labels: Blue Ocean Strategy and Shift Tools
  - 9.2.4.1. Value Innovation
  - 9.2.4.2. Strategy Canvas
  - 9.2.4.3. Four Action Framework
  - 9.2.4.4. Eliminate-Raise-Reduce-Create (ERRC) Grid
  - 9.2.4.5. Six Path Framework
  - 9.2.4.6. Pioneer-Migrator-Settler (PMS) Map
  - 9.2.4.7. Three Tiers of Noncustomers
  - 9.2.4.8. Sequence of Blue Ocean Strategy
  - 9.2.4.9. Buyer Utility Map
  - 9.2.4.10. The Price Corridor of the Mass
  - 9.2.4.11. Four Hurdles to Strategy Execution
  - 9.2.4.12. Tipping Point Leadership
  - 9.2.4.13. Fair Process
9.3. Concluding Remarks

10. MARKET SIZING AND OPPORTUNITY ANALYSIS

10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Global Smart Pharmaceutical and Healthcare Labels Market, 2022-2035
10.4. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Technology, 2022-2035
- 10.4.1. Smart Pharmaceutical and Healthcare Labels Market for RFID, 2022-2035
- 10.4.2. Smart Pharmaceutical and Healthcare Labels Market for NFC, 2022-2035
- 10.4.3. Smart Pharmaceutical and Healthcare Labels Market for Other Technologies, 2022-2035
10.5. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Packaging, 2022-2035
- 10.5.1. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Primary Packaging, 2022-2035
  - 10.5.1.1. Smart Pharmaceutical and Healthcare Labels Market for Vials, 2022-2035
  - 10.5.1.2. Smart Pharmaceutical and Healthcare Labels Market for Syringes, 2022-2035
  - 10.5.1.3. Smart Pharmaceutical and Healthcare Labels Market for Cartridges, 2022-2035
  - 10.5.1.4. Smart Pharmaceutical and Healthcare Labels Market for Ampoules, 2022-2035
  - 10.5.1.5. Smart Pharmaceutical and Healthcare Labels Market for Bottles, 2022-2035
  - 10.5.1.6. Smart Pharmaceutical and Healthcare Labels Market for Blister Packs, 2022-2035
- 10.5.2. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Type of Secondary Packaging, 2022-2035
  - 10.5.2.1. Smart Pharmaceutical and Healthcare Labels Market for Boxes, 2022-2035
  - 10.5.2.2. Smart Pharmaceutical and Healthcare Labels Market for Cartons, 2022-2035
  - 10.5.2.3. Smart Pharmaceutical and Healthcare Labels Market for Pouches, 2022-2035
10.6. Smart Pharmaceutical and Healthcare Labels Market: Analysis by Geography, 2022-2035
- 10.6.1. Smart Pharmaceutical and Healthcare Labels Market in North America, 2022-2035
- 10.6.2. Smart Pharmaceutical and Healthcare Labels Market in Europe, 2022-2035
- 10.6.3. Smart Pharmaceutical and Healthcare Labels Market in Asia-Pacific, 2022-2035
- 10.6.4. Smart Pharmaceutical and Healthcare Labels Market in MENA, 2022-2035
- 10.6.5. Smart Pharmaceutical and Healthcare Labels Market in Latin America, 2022-2035

11. SWOT ANALYSIS

11.1. Chapter Overview
11.2. Strengths
11.3. Weaknesses
11.4. Opportunities
11.5. Threats
11.6. Comparison of SWOT Factors

12. CONCLUDING REMARKS

13. APPENDIX I: TABULATED DATA

14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS